Skip to main content
BIOXYNE LIMITED logo

BIOXYNE LIMITED — Investor Relations & Filings

Ticker · BXN ISIN · AU000000BXN6 LEI · 984500F02D2B1B94E956 ASX Manufacturing
Open in API
Filings indexed 843 across all filing types
Latest filing 2020-08-20 Regulatory Filings
Country AU Australia
Listing ASX BXN

About BIOXYNE LIMITED

https://bioxyne.com

Bioxyne Limited is a life sciences company focused on the development, manufacture, and commercialization of health and wellness products. The company specializes in proprietary probiotic strains, notably the Lactobacillus fermentum VRI-003 (PCC), which is utilized in supplements targeting immune health and gut function. Following the acquisition of Breathe Life Sciences, Bioxyne has expanded its portfolio into the medicinal cannabis sector, novel foods, and consumer health products. Its operations encompass the production and distribution of pharmaceutical-grade cannabis products, CBD-based wellness items, and functional supplements. The company serves international markets through a vertically integrated model, focusing on research-driven formulations and high-quality manufacturing standards to address growing consumer demand for therapeutic and preventative health solutions.

Recent filings

Filing Released Lang Actions
Response to ASX Price Query 5 pages 436.7KB
Regulatory Filings Classification · 95% confidence The document is a letter from ASX Compliance to Bioxyne Limited regarding a price query due to unusual trading activity in the company's securities. It requests information about any undisclosed material information, particularly earnings for the 12 months ending 30 June 2020, and compliance with listing rules. The document is a regulatory inquiry and response, not a financial report or earnings release. It does not contain financial statements or detailed financial data but is a compliance and disclosure communication. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2020-08-20 English
Appendix 4C - quarterly 8 pages 424.0KB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Quarterly Report for the Quarter Ended 30 June 2020' and contains detailed financial data including sales revenue, operating loss, cash flow statements, and cash equivalents. It includes a comprehensive Appendix 4C cash flow report as required by ASX Listing Rule 4.7B, which is a standard quarterly financial reporting requirement for Australian listed companies. The document is about 15,000 characters long, indicating it is a full report rather than a brief announcement. The content includes substantive financial data and analysis for a period shorter than a full fiscal year (a quarter), which fits the definition of an Interim / Quarterly Report (IR). There is no indication that this is merely an announcement of a report or a certification, so it is not classified as RPA or RNS. Therefore, the correct classification is Interim / Quarterly Report (IR). Q4 2020
2020-07-30 English
Appendix 4C Revised 9 pages 473.7KB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'QUARTERLY REPORT FOR THE QUARTER ENDED 31 MARCH 2020' and contains detailed financial and operational information for the quarter, including revenue, losses, cash flow statements, and operational highlights. It includes a consolidated statement of cash flows and compliance statements referencing ASX Listing Rule 4.7B, which is typical for quarterly reports. The document is approximately 15,000 characters long, indicating it is a full report rather than a brief announcement. The content is consistent with a comprehensive interim or quarterly financial report containing substantive financial data and analysis, not just a summary or announcement. Therefore, the appropriate classification is Interim / Quarterly Report (IR). Q3 2020
2020-04-30 English
Appendix 4C - quarterly 9 pages 436.7KB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'QUARTERLY REPORT FOR THE QUARTER ENDED 31 MARCH 2020' and contains detailed financial and operational information for the quarter, including revenue, losses, cash flow statements, and operational highlights. It includes a full Appendix 4C cash flow report as required by ASX Listing Rule 4.7B, which is a standard quarterly report for Australian listed entities. The document is approximately 15,000 characters long, indicating it is a full report rather than a brief announcement. The content includes actual financial data and analysis for the quarter, not just a summary or announcement of a report. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). Q3 2020
2020-04-29 English
Market Update 3 pages 320.5KB
Capital/Financing Update Classification · 85% confidence The document is an ASX announcement dated 14 April 2020 providing a market update on Bioxyne Limited's operations, including product revenue for the 9 months to 31 March 2020, impact of COVID-19 on development, product registrations, and cost-saving initiatives. It contains operational and financial highlights but does not include detailed financial statements or comprehensive financial analysis typical of an Interim/Quarterly Report. The document is longer than 5,000 characters and provides substantive information rather than just announcing the release of a report. It is not a full Annual Report or Earnings Release, nor is it a regulatory filing or certification. The content fits best as a Capital/Financing Update or Market Update, but since it focuses on operational and revenue updates without new financing or capital structure changes, the closest fitting category is Capital/Financing Update (CAP) as it updates the market on company performance and outlook in the context of COVID-19 and business operations.
2020-04-13 English
Appendix 4D and Half Year Accounts 21 pages 699.2KB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Appendix 4D – Half Year Report' and covers the half year ended 31 December 2019. It includes detailed financial statements such as the Statement of Profit or Loss and Other Comprehensive Income, Statement of Financial Position, Statement of Changes in Equity, and Notes to the Financial Statements. It also contains a Directors' Report and an Independent Auditor's Review Report. The content is comprehensive and includes actual financial data and analysis for the half-year period, which aligns with the definition of an Interim / Quarterly Report (IR). The document is about 15,000 characters long, indicating it is a full report rather than a brief announcement or certification. Therefore, the appropriate classification is Interim / Quarterly Report (IR). H1 2020
2020-02-27 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.